The information on this page is based on a number of underlying datasets, most of which are updated monthly. We maintain an update schedule which explains which version of each dataset we are currently relying on.
43 CAPEL POINT is a midsized flat of 67m², built sometime between 1983 and 1990, which could now be worth an estimated £223,946. It was last sold for £143,000 in May 2007, which was around 34% below the average May 2007 flat price in the Newham local authority area. The most recent EPC inspection was May 2021, where the current energy rating was C, and the potential energy rating was C.
Land registry data shows one sale for 43 CAPEL POINT since 1st January 1995. The below table shows the price paid for the one sale, along with the average flat price in the Newham local authority area for the corresponding sale date. The average price is sourced from the Office for National Statistics' House Price Index (HPI).
| Date | Price | HPI Price | Variation from HPI |
|---|---|---|---|
2007 18 MAY | £143,000 | £216,143 | 34% below HPI |
43 CAPEL POINT might now be worth an estimated £223,946.
This is based on house price inflation of 56.6%, between May 2007 and May 2026, for flats, in the Newham local authority area, as calculated by the Office for National Statistics and published in their UK House Price Index (HPI).
The 56.6% inflationary increase is applied to the most recent sale price for 43 CAPEL POINT of £143,000 on 18th May 2007. For the value to have increased from £143,000 to £223,946 over the nineteen years to May 2026, the following assumptions must hold true:
43 CAPEL POINT is 67m² according to the EPC inspection conducted in May 2021. This puts it in the largest 40% of flats in London, based on EPC data. 59% of flats are smaller than 43 CAPEL POINT, and 39% of flats are larger. Note that EPC data is not available for all properties in London.
43 CAPEL POINT sits on a plot of roughly 0.465 of an acre, or 1,882m².
43 CAPEL POINT is located on CAPEL ROAD in LONDON, in the E7 postcode district.
Most recent sales first: